To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T ...

Late last year, the therapy developers dosed their first patient following positive preclinical data demonstrating safety and ...

The virus likely reached humans not via bat migration but through the wildlife trade—contradicting hypotheses that it may ...

Gene therapies offer incredible promise for treating diseases with a genetic component. Several gene therapies are already ...

Researchers expect LICONN technology will be broadly useful to enable high-resolution tissue analysis in other organs and ...

Single-cell biology has transformed how we decode cellular heterogeneity, but a new frontier is emerging: understanding what ...

Careful planning can make a substantial difference on your path to commercial success. Here we delve into key considerations ...

Although gene-editing and other techniques can improve the production of microbe-based biologics, AI could push these drugs ...

There is a consistent need from researchers to manufacture a cGMP virus to support the advancement of gene therapies.

The ECOnti project's aim is to fit the entire manufacturing site into a small footprint as part of bioproduction democratization.

Attributing manufacturing problems to “human error” is an oversimplification that can mask deeper failures, according to Ann Ryan, head of business development at Ireland-based training and technology ...